Search
NeuroOne Medical Technologies Corp
NMTCAdd to Watchlist
3.000USD
-0.040-1.32%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
26.11MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of NeuroOne Medical Technologies Corp is 8.67, ranking 16 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 2.23, with a high of 3.00 and a low of 1.45.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
9.933
Target Price
+226.75%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
96
Total
3
Median
6
Average
Company name
Ratings
Analysts
NeuroOne Medical Technologies Corp
NMTC
3
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is NeuroOne Medical Technologies Corp's expected revenue for the next quarter?
NeuroOne Medical Technologies Corp's expected revenue is 2.55M.
What is NeuroOne Medical Technologies Corp's price target?
Analysts forecast that NeuroOne Medical Technologies Corp's price target is USD 2.23, with the highest forecast at USD 3.00 and the lowest forecast at USD 1.45.
How have NeuroOne Medical Technologies CorpNMTC's recent earnings per share performed?
The market expectation was USD -0.25, while NeuroOne Medical Technologies CorpNMTC's earnings per share (EPS) for the previous quarter was USD -0.17. EPS for the next quarter is expected at USD -0.22.
What is the analyst rating for NeuroOne Medical Technologies Corp?
Based on the ratings of NeuroOne Medical Technologies Corp's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.